When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.


Empowering a community publishing articles in Immunotherapy, Vaccines, Autoimmune diseases, Immunodeficiencies, Transplantation, Allergy, Tumour Immunology, Adaptive immunity, Innate immunity

To date, over 10,763 articles in Immunology have been published with more than 200,273 citations from authors in 147 countries.

PLOS empowers Immunology researchers to discuss, evaluate and improve science.

Our community is a collaboration between authors, editors and reviewers. In-house editorial subject experts work alongside section editors, academic editors, and journal editorial boards to provide accurate assessment that readers can trust.

We put research and researchers first, collaborating to make science, and the process of publishing science, fair, equitable, and accessible for the whole community.

…Open Science is crucial for the scientific outcome; results must be shared and reproduced in order to move on to the next level, developing new human therapies. This is what I want, and why I do research. To help each other to make the world a better place, step-by-step, no matter how small.
  • Share your opinion!

In recent years, scientists and scientific journal editors have expressed concern that many of the results of published research may be false or irreproducible.

How concerned are you that the research published in your field is not reproducible?


PLOS will be attending a number of Immunology related events through 2020. More details to follow.

Back to top